INKT

MiNK Therapeutics, Inc. - Common Stock (INKT)

About MiNK Therapeutics, Inc. - Common Stock (INKT)

MiNK Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of allogeneic invariant natural killer T cell therapies to treat cancer and other immune mediated diseases. The company was founded by Garo H. Armen in 2017 and is headquartered in New York, NY.

Details

Daily high

$10.49

Daily low

$9.61

Price at open

$10.49

52 Week High

$16.93

52 Week Low

$8.48

Market cap

54.1M

Dividend yield

Volume

15,186

Avg. volume

11,895

P/E ratio

-4.42

MiNK Therapeutics, Inc. - Common Stock News

Details

Daily high

$10.49

Daily low

$9.61

Price at open

$10.49

52 Week High

$16.93

52 Week Low

$8.48

Market cap

54.1M

Dividend yield

Volume

15,186

Avg. volume

11,895

P/E ratio

-4.42